Tina Marriott - Mar 4, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
President and COO
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Mar 4, 2022
Transactions value $
$62,010
Form type
4
Date filed
3/8/2022, 07:55 PM
Previous filing
Feb 22, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $62K +58.5K +39.13% $1.06* 208K Mar 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 +58.5K +10.17% $0.00 634K Mar 4, 2022 Class A Common Stock 634K $1.06 Direct F1
holding RXRX Stock Option (Right to Buy) 159K Mar 4, 2022 Class A Common Stock 159K $11.40 Direct F2
holding RXRX Stock Option (Right to Buy) 4.78K Mar 4, 2022 Class A Common Stock 4.78K $11.40 Direct
holding RXRX Stock Option (Right to Buy) 150K Mar 4, 2022 Class A Common Stock 150K $2.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
F2 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F3 One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.